Anzeige
Meldung des Tages: Großes Umsatzwachstum: Warum ein Hidden Champion im Drohnenmarkt gerade Aufmerksamkeit bekommt

OREXO AB News

Aktie
WKN:  ISIN:  US68616W1027 US-Symbol:  ORXOY
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

OREXO AB News

06.03.26 - PR Newswire
Invitation & Agenda: Orexo R&D Day on March 24
Invitation & Agenda: Orexo R&D Day on March 24 PR Newswire
06.03.26 - PR Newswire
Invitation & Agenda: Orexo R&D Day on March 24
Invitation & Agenda: Orexo R&D Day on March 24 PR Newswire
06.03.26 - PR Newswire
Orexo changes the organizational structure and management team to increase focus on development of new products
Orexo changes the organizational structure and management team to increase focus on development of new products PR Newswire
06.03.26 - PR Newswire
Orexo changes the organizational structure and management team to increase focus on development of new products
Orexo changes the organizational structure and management team to increase focus on development of new products PR Newswire
05.09.25 - PR Newswire
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication PR Newswire
05.09.25 - PR Newswire
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication PR Newswire
02.06.25 - PR Newswire
Orexo to present clinical data for OX640 at the EAACI Congress
Orexo to present clinical data for OX640 at the EAACI Congress PR Newswire
02.06.25 - PR Newswire
Orexo to present clinical data for OX640 at the EAACI Congress
Orexo to present clinical data for OX640 at the EAACI Congress PR Newswire
10.04.25 - PR Newswire
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
Orexo announces positive data for powder-​based intranasal vaccine formulated with the AmorphOX technology PR Newswire
10.04.25 - PR Newswire
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
Orexo announces positive data for powder-​based intranasal vaccine formulated with the AmorphOX technology PR Newswire
10.01.25 - PR Newswire
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis PR Newswire
10.01.25 - PR Newswire
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis PR Newswire
17.12.24 - PR Newswire
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology PR Newswire
17.12.24 - PR Newswire
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology
Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology PR Newswire
25.10.24 - PR Newswire
Orexo initiates new study of OX640 in participants with allergic rhinitis
Orexo initiates new study of OX640 in participants with allergic rhinitis PR Newswire
25.10.24 - PR Newswire
Orexo initiates new study of OX640 in participants with allergic rhinitis
Orexo initiates new study of OX640 in participants with allergic rhinitis PR Newswire
24.10.24 - PR Newswire
Orexo Interim Report Q3 2024
Orexo Interim Report Q3 2024 PR Newswire
24.10.24 - PR Newswire
Orexo Interim Report Q3 2024
Orexo Interim Report Q3 2024 PR Newswire
04.10.24 - PR Newswire
Orexo´s Nomination Committee for the Annual General Meeting 2025
Orexo´s Nomination Committee for the Annual General Meeting 2025 PR Newswire
04.10.24 - PR Newswire
Orexo´s Nomination Committee for the Annual General Meeting 2025
Orexo´s Nomination Committee for the Annual General Meeting 2025 PR Newswire

Newssuche

Videos

newspaper
10:40 Uhr +38,58%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »